Pharmacological treatment of cognitive impairment

Details for Australian Patent Application No. 2007267988 (hide)

Owner The Board of Trustees of the Leland Stanford Junior University

Inventors Garner, Craig C.; Fernandez, Fabian J.

Agent FB Rice

Pub. Number AU-A-2007267988

PCT Pub. Number WO2007/139818

Priority 60/802,760 22.05.06 US

Filing date 22 May 2007

Wipo publication date 6 December 2007

International Classifications

A61K 31/34 (2006.01) - having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 47/00 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

G01N 33/00 (2006.01) Investigating or analysing materials by specific methods not covered by groups

G01N 33/567 (2006.01) Investigating or analysing materials by specific methods not covered by groups - utilising isolate of tissue or organ as binding agent

Event Publications

22 January 2009 PCT application entered the National Phase

  PCT publication WO2007/139818 Priority application(s): WO2007/139818

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007267989-System and method for defining billable labor by setting profit

2007267986-Thiophene-carboxamides useful as inhibitors of protein kinases